244 related articles for article (PubMed ID: 37414071)
1. Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial.
Svanevik M; Lorentzen J; Borgeraas H; Sandbu R; Seip B; Medhus AW; Hertel JK; Kolotkin RL; Småstuen MC; Hofsø D; Hjelmesæth J
Lancet Diabetes Endocrinol; 2023 Aug; 11(8):555-566. PubMed ID: 37414071
[TBL] [Abstract][Full Text] [Related]
2. Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial.
Hofsø D; Fatima F; Borgeraas H; Birkeland KI; Gulseth HL; Hertel JK; Johnson LK; Lindberg M; Nordstrand N; Cvancarova Småstuen M; Stefanovski D; Svanevik M; Gretland Valderhaug T; Sandbu R; Hjelmesæth J
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):912-924. PubMed ID: 31678062
[TBL] [Abstract][Full Text] [Related]
3. Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity
Borgeraas H; Hjelmesæth J; Birkeland KI; Fatima F; Grimnes JO; Gulseth HL; Halvorsen E; Hertel JK; Hillestad TOW; Johnson LK; Karlsen TI; Kolotkin RL; Kvan NP; Lindberg M; Lorentzen J; Nordstrand N; Sandbu R; Seeberg KA; Seip B; Svanevik M; Valderhaug TG; Hofsø D
BMJ Open; 2019 Jun; 9(6):e024573. PubMed ID: 31167860
[TBL] [Abstract][Full Text] [Related]
4. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
Salminen P; Helmiö M; Ovaska J; Juuti A; Leivonen M; Peromaa-Haavisto P; Hurme S; Soinio M; Nuutila P; Victorzon M
JAMA; 2018 Jan; 319(3):241-254. PubMed ID: 29340676
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic Sleeve Gastrectomy Versus Banded Roux-en-Y Gastric Bypass for Diabetes and Obesity: a Prospective Randomised Double-Blind Trial.
Murphy R; Clarke MG; Evennett NJ; John Robinson S; Lee Humphreys M; Hammodat H; Jones B; Kim DD; Cutfield R; Johnson MH; Plank LD; Booth MWC
Obes Surg; 2018 Feb; 28(2):293-302. PubMed ID: 28840525
[TBL] [Abstract][Full Text] [Related]
6. Surgery for weight loss in adults.
Colquitt JL; Pickett K; Loveman E; Frampton GK
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
[TBL] [Abstract][Full Text] [Related]
7. Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol.
Murphy R; Evennett NJ; Clarke MG; Robinson SJ; Humphreys L; Jones B; Kim DD; Cutfield R; Plank LD; Hammodat H; Booth MW
BMJ Open; 2016 Jul; 6(7):e011416. PubMed ID: 27377635
[TBL] [Abstract][Full Text] [Related]
8. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
[TBL] [Abstract][Full Text] [Related]
9. Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial.
Seeberg KA; Borgeraas H; Hofsø D; Småstuen MC; Kvan NP; Grimnes JO; Lindberg M; Fatima F; Seeberg LT; Sandbu R; Hjelmesæth J; Hertel JK
Ann Intern Med; 2022 Jan; 175(1):74-83. PubMed ID: 34843380
[TBL] [Abstract][Full Text] [Related]
10. Changes in dietary intake, food tolerance, hedonic hunger, binge eating problems, and gastrointestinal symptoms after sleeve gastrectomy compared with after gastric bypass; 1-year results from the Oseberg study-a randomized controlled trial.
Barstad LH; Johnson LK; Borgeraas H; Hofsø D; Svanevik M; Småstuen MC; Hertel JK; Hjelmesæth J
Am J Clin Nutr; 2023 Mar; 117(3):586-598. PubMed ID: 36811476
[TBL] [Abstract][Full Text] [Related]
11. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Nanni G; Castagneto M; Bornstein S; Rubino F
Lancet; 2015 Sep; 386(9997):964-73. PubMed ID: 26369473
[TBL] [Abstract][Full Text] [Related]
12. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
Grönroos S; Helmiö M; Juuti A; Tiusanen R; Hurme S; Löyttyniemi E; Ovaska J; Leivonen M; Peromaa-Haavisto P; Mäklin S; Sintonen H; Sammalkorpi H; Nuutila P; Salminen P
JAMA Surg; 2021 Feb; 156(2):137-146. PubMed ID: 33295955
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and bariatric surgery versus intensive non-surgical treatment for adolescents with severe obesity (AMOS2): a multicentre, randomised, controlled trial in Sweden.
Järvholm K; Janson A; Peltonen M; Neovius M; Gronowitz E; Engström M; Laurenius A; Beamish AJ; Dahlgren J; Sjögren L; Olbers T
Lancet Child Adolesc Health; 2023 Apr; 7(4):249-260. PubMed ID: 36848922
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.
Han Y; Jia Y; Wang H; Cao L; Zhao Y
Int J Surg; 2020 Apr; 76():101-110. PubMed ID: 32151750
[TBL] [Abstract][Full Text] [Related]
15. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients.
Bruno G; Gruden G; Barutta F; Cavallo Perin P; Morino M; Toppino M
Surg Obes Relat Dis; 2015; 11(5):1014-9. PubMed ID: 25979204
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.
Ruiz-Tovar J; Carbajo MA; Jimenez JM; Castro MJ; Gonzalez G; Ortiz-de-Solorzano J; Zubiaga L
Surg Endosc; 2019 Feb; 33(2):401-410. PubMed ID: 29943058
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey.
Musella M; Apers J; Rheinwalt K; Ribeiro R; Manno E; Greco F; Čierny M; Milone M; Di Stefano C; Guler S; Van Lessen IM; Guerra A; Maglio MN; Bonfanti R; Novotna R; Coretti G; Piazza L
Obes Surg; 2016 May; 26(5):933-40. PubMed ID: 26341086
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass).
Biter LU; 't Hart JW; Noordman BJ; Smulders JF; Nienhuijs S; Dunkelgrün M; Zengerink JF; Birnie E; Friskes IA; Mannaerts GH; Apers JA
Lancet Reg Health Eur; 2024 Mar; 38():100836. PubMed ID: 38313139
[TBL] [Abstract][Full Text] [Related]
20. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.
Salminen P; Grönroos S; Helmiö M; Hurme S; Juuti A; Juusela R; Peromaa-Haavisto P; Leivonen M; Nuutila P; Ovaska J
JAMA Surg; 2022 Aug; 157(8):656-666. PubMed ID: 35731535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
